In human ovarian cancer cells, p62 efficiently regulated the Keap1–Nrf2–ARE system to mediate cisplatin resistance, avoiding oxidative stress‐induced apoptosis 9. This evidence concerns the gene KEAP1 and ovarian carcinoma.